Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 63, Number 20 Supplement 6, S16-S22
Copyright © 2006 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edelsberg, J.
Right arrow Articles by Oster, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edelsberg, J.
Right arrow Articles by Oster, G.

Risk of venous thromboembolism among hospitalized medically ill patients

John Edelsberg, May Hagiwara, Charu Taneja and Gerry Oster

JOHN EDELSBERG, M.D., M.P.H., is Medical Director; MAY HAGIWARA, PH.D., is Senior Analyst; CHARU TANEJA, M.P.H., is Research Associate; and GERRY OSTER, PH.D., is Vice President, Policy Analysis Inc., Brookline, MA.

Address correspondence to Dr. Oster at Policy Analysis Inc., Four Davis Court, Brookline, MA 02445 (goster{at}pai2.com).


Purpose. The 90-day risk of venous thromboembolism (VTE) among medically ill patients admitted to a hospital was estimated and is discussed.

Summary. Patients aged ≥40 years who were hospitalized between January 1, 1998, and June 30, 2002, for reasons other than traumatic injury, labor and delivery, mental disorder, or VTE and who did not undergo surgery were identified in a large U.S. healthcare claims database. Patients receiving anticoagulants in the 90-day period preceding hospital admission were excluded. We estimated the percentage of study subjects who developed clinical deep-vein thrombosis (DVT) or pulmonary embolism (PE) within 90 days of hospital admission using Kaplan–Meier methods. We also estimated hazard ratios (HRs) for potential risk factors for VTE using univariate and stepwise multivariate Cox proportional hazards regression models.

Among 92,162 study subjects, 1468 (1.59%) developed clinical DVT or PE within 90 days of hospital admission; 18% of these events occurred postdischarge. In multivariate analyses, significant risk factors for clinical VTE included: 1) history of cancer (HR, 1.67; 95% confidence interval [CI], 1.45–1.93); 2) history of VTE within six months of index admission (HR, 6.14; 95% CI, 4.74–7.96); 3) operating room procedure within 30 days of index admission (HR, 1.81; 95% CI, 1.47–2.24); 4) peripheral artery disease during index admission (HR, 1.68; 95% CI, 1.28–2.21); and 5) heart failure during index admission (HR, 1.72; 95% CI, 1.52–1.95).

Conclusion. The risk of clinical VTE among medically ill patients admitted to a hospital, although less than that of patients undergoing major surgery, is not negligible. Patients with a history of recent VTE or surgery, those who are admitted to the intensive care unit, those with an admitting diagnosis of heart failure, and those with active cancer are at especially high risk of VTE and deserve increased consideration for prophylaxis.

Index terms: Heart failure; Hospitals; Neoplasms; Peripheral vascular diseases; Surgery; Thromboembolism

 



This article has been cited by other articles:


Home page
HypertensionHome page
M. Masoud, G. Sarig, B. Brenner, and G. Jacob
Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System
Hypertension, June 1, 2008; 51(6): 1545 - 1551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Health-System Pharmacists.